{"id":"W2155567491","doi":"10.1016/j.jacc.2009.04.007","title":"End Points and Clinical Trial Design in Pulmonary Arterial Hypertension","year":2009,"lang":"en","type":"review","venue":"Journal of the American College of Cardiology","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":253,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"Pfizer","keywords":"Medicine; Clinical trial; Pulmonary hypertension; End point; Intensive care medicine; Clinical endpoint; Modalities; Clinical study design; Randomized controlled trial; Placebo; Quality of life (healthcare); Cardiology; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001742811,0.0003145868,0.005789781,0.000432452,0.00004136557,0.000003806859,0.0003106413,0.0002482677,0.000006531037],"category_scores_gemma":[0.001183355,0.0001657419,0.001483383,0.0004401334,0.0006896424,0.00004109435,0.0001337792,0.0008939725,0.000002969723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001156386,"about_ca_system_score_gemma":0.001222273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005814808,"about_ca_topic_score_gemma":5.195586e-7,"domain_scores_codex":[0.9943564,0.002880564,0.001699188,0.0002937593,0.0004502156,0.0003198619],"domain_scores_gemma":[0.9960775,0.001390342,0.001620023,0.000449645,0.0002103356,0.0002521871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.09270113,0.0009589698,0.0007795581,0.0005335839,0.002334739,0.05023175,0.000001273064,0.000001340099,0.00002326696,0.000007478384,0.005592427,0.8468345],"study_design_scores_gemma":[0.04768592,0.02979244,0.01689937,0.009185472,0.006639733,0.1536082,0.00005833489,0.00002598156,0.00000240639,0.000364046,0.7353139,0.000424194],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02615036,0.9700083,0.00001274437,0.0008867599,0.0009930895,0.001664323,0.00007200205,0.00000435352,0.0002080912],"genre_scores_gemma":[0.009802061,0.9881248,0.0007841143,0.0001744302,0.001003044,0.000007399794,0.000004342808,0.0000266769,0.00007309404],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8464103,"threshold_uncertainty_score":0.675876,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1096870490308459,"score_gpt":0.3924779982567499,"score_spread":0.282790949225904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}